CD40 and coronary artery disorder: In addition, the proteomic and genomic analysis in plasma and vascular bypass tissue of CHD patients without comorbidities or with the comorbidities hypertension and/or hypertension + diabetes identified some key mediators of CD40(L)–TRAF signaling, centered around TNFα.